0000882104-20-000197.txt : 20201204 0000882104-20-000197.hdr.sgml : 20201204 20201204211730 ACCESSION NUMBER: 0000882104-20-000197 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201202 FILED AS OF DATE: 20201204 DATE AS OF CHANGE: 20201204 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Stone Christopher Lewis CENTRAL INDEX KEY: 0001453373 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19756 FILM NUMBER: 201371197 MAIL ADDRESS: STREET 1: 932 SOUTHWOOD BLVD. CITY: INCLINE VILLAGE STATE: NV ZIP: 89451 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PDL BIOPHARMA, INC. CENTRAL INDEX KEY: 0000882104 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943023969 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 932 SOUTHWOOD BLVD CITY: INCLINE VILLAGE STATE: NV ZIP: 89451 BUSINESS PHONE: 775-832-8500 MAIL ADDRESS: STREET 1: 932 SOUTHWOOD BLVD CITY: INCLINE VILLAGE STATE: NV ZIP: 89451 FORMER COMPANY: FORMER CONFORMED NAME: PROTEIN DESIGN LABS INC/DE DATE OF NAME CHANGE: 19930328 4 1 wf-form4_160713463756912.xml FORM 4 X0306 4 2020-12-02 0 0000882104 PDL BIOPHARMA, INC. PDLI 0001453373 Stone Christopher Lewis C/O PDL BIOPHARMA, INC. 932 SOUTHWOOD BLVD. INCLINE VILLAGE NV 89451 0 1 0 0 VP, Gen. Counsel & Secretary Common stock 2020-12-02 4 D 0 11544 0 D 605559 D Disposition of a portion of a restricted stock award due to performance criteria not being achieved under equity incentive plans. /s/ Nathan Kryszak, Attorney-in-Fact for Christopher Stone 2020-12-04